Tag: biotechnology
-
FDA Grants Priority Review for Gene Therapy
A biotechnology company making gene therapies to treat rare diseases says the Food and Drug Administration granted an accelerated review for its treatment of an inherited eye disorder.
-
Grant Funding Automated Genome Editing System
A consortium of companies and university in the U.K. and U.S. are developing an automated desktop genome editing system using the emerging Crispr technique.
-
Nanotech Treatment Studied for Brain Tumors
Medical researchers and engineers designed and tested in mice a way to deliver gene-silencing therapies in nanoscale particles to treat glioblastoma, an aggressive form of brain cancer.
-
Broad Institute in Crispr Licensing Program
One of the key inventors of a genome editing technique known as Crispr is joining a program that promises to ease licensing of its patents for the technology.
-
Feasibility, Safety Shown for Personal Tumor Vaccine
A pilot study among individuals with a form of skin cancer shows a vaccine aiming at proteins specific to a person’s tumor is safe and can generate a complex immune response attacking the tumor.
-
Glaxo Using Artificial Intelligence for Drug Discovery
Drug maker GlaxoSmithKline is hiring a company that applies artificial intelligence for drug discovery and design to identify new small-molecule compounds for up to 10 disease targets.
-
Second Trial Approved for Cancer Pain Drug
The U.S. Food and Drug Administration approved a new clinical trial to test the efficacy and safety of an experimental drug designed to relieve stubborn chronic pain associated with cancer.
-
Simple, Inexpensive Pathogen Detector Developed
A simple and inexpensive detection device is being created to find disease-causing microbes in samples of food, water, and human specimens.
-
Preclinical Data Show Promise for Diabetic Eye Drug
Early evidence shows a drug designed as eye drops to treat diabetic macular edema, an eye disease in people with diabetes, permeates the entire eye, including the retina.
-
Computer-Designed Antibodies Target Alzheimer’s Proteins
Researchers in Europe designed antibodies, like those in the immune system, to attack protein deposits in the brain associated with Alzheimer’s disease.